CAR T-cell therapy rescues adolescent with rapidly progressive lupus nephritis from haemodialysis

Tobias Krickau(Universitätsklinikum Erlangen), Nora Naumann‐Bartsch(Universitätsklinikum Erlangen), Michael Aigner(Friedrich-Alexander-Universität Erlangen-Nürnberg), Soraya Kharboutli(Friedrich-Alexander-Universität Erlangen-Nürnberg), Sascha Kretschmann(Huawei German Research Center), Silvia Spoerl(Huawei German Research Center), Ingrid Vášová(Universitätsklinikum Erlangen), Simon Völkl(Universitätsklinikum Erlangen), Joachim Woelfle(Friedrich-Alexander-Universität Erlangen-Nürnberg), Andréas Mackensen(Huawei German Research Center), Georg Schett(Universitätsklinikum Erlangen), Markus Metzler(Universitätsklinikum Erlangen), Fabian Müller(Huawei German Research Center)
The Lancet
April 1, 2024
10.1016/s0140-6736(24)00424-0
Cited by 102Open Access
Full Text

Abstract

Related Papers

Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
George Βertsias, Maria G. Tektonidou, Zahir Amoura et al.|Annals of the Rheumatic Diseases|2012|1k
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
Andréas Mackensen, Fabian Müller, Dimitrios Mougiakakos et al.|Nature Medicine|2022|967
CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up
Fabian Müller, Jule Taubmann, Laura Bucci et al.|New England Journal of Medicine|2024|897
Difference in disease features between childhood‐onset and adult‐onset systemic lupus erythematosus
Hermine I. Brunner, Dafna D. Gladman, Dominique Ibañez et al.|Arthritis & Rheumatism|2008|552
CAR T-cell therapy in autoimmune diseases
Georg Schett, Georg Schett, Andréas Mackensen et al.|The Lancet|2023|360